Overview
Compare with Corporate Office Properties Trust, American Assets Trust, Inc. or CIM Commercial Trust Corporation, or pick any stock.
- TickerGBCS on OTC1
- IndustryReal Estate Investment Trusts1
- HeadquartersGreenwood Village, Colorado1
- Incorporated inUT2
- Business address8480 E. Orchard Road, Suite 4900, Greenwood Village, Co 801112
- Filer category, Emerging growth company2
See how the biggest companies compare on our leaderboards
Paces Ferry Healthcare REIT, Inc. (“WPF”). WPF was merged into the Company in 2019.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Health Care brought in 100% of the revenue SELECTIS HEALTH, INC. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2024 | 2025 |
|---|---|---|
| Health Care | $39.2M | $41.4M |
| Management Fee Revenue | $65.8K |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Other costs100¢$41.4M
- Income tax0¢$800
Out of $41.4M in revenue.4 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Capital spending24¢$443.6K
- Kept or used elsewhere76¢$1.4M
Out of $1.9M of cash from operations.4
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Total Revenue | $41.4M | $39.5M |
| Property taxes, insurance and other operating | $31.8M | $30.4M |
| General and administrative | $8.9M | $9.2M |
| Provision for credit losses | $883.0K | $1.0M |
| Depreciation and amortization | $1.5M | $1.6M |
| Total operating expenses | $43.0M | $42.2M |
| Loss from Operations | -$1.6M | -$2.7M |
| Gain on sale of asset | -$2.1M | |
| Interest Expense, net | $1.7M | $2.0M |
| Loss on debt extinguishment | $253.0K | |
| Income from employee retention credits | -$986.4K | |
| Other income, net | -$1.5M | -$240.0K |
| Total other income, net | -$549.7K | -$305.2K |
| Loss before taxes | -$1.0M | -$2.4M |
| Provision for income taxes | $800 | |
| Net Loss | -$1.0M | -$2.4M |
| Series D preferred dividends | -$37.5K | -$22.5K |
| Net Loss Attributable to Common Stockholders | -$1.1M | -$2.4M |
| Basic | -$0.34 | -$0.80 |
| Diluted | -$0.34 | -$0.80 |
| Basic | 3.1M shares | 3.1M shares |
| Diluted | 3.1M shares | 3.1M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $1.0M | $680.3K | |
| Accounts receivable, net | $2.3M | $2.6M | |
| Other receivable | $123.1K | ||
| Prepaid expenses and other assets | $149.8K | $233.2K | |
| Assets held for sale | $4.0M | ||
| Total current assets | $7.6M | $3.5M | |
| Restricted cash | $842.1K | $711.6K | |
| Property and equipment, net | $23.1M | $28.1M | |
| Goodwill | $1.1M | $1.1M | $1.1M |
| Total Assets | $32.6M | $33.4M | |
| Accounts payable and accrued liabilities | $6.3M | $6.6M | |
| Dividends payable | $89.6K | $53.1K | |
| Current long-term debt, net of discount of $6,544 and $451,936, respectively | $10.9M | $11.5M | |
| Lines of credit | $325.2K | $799.8K | |
| Liabilities held for sale, net of discount of $231,196 | $6.1M | ||
| Other current liabilities | $725.0K | ||
| Total Current Liabilities | $25.3M | $19.6M | |
| Long-term debt, net of discount of $197,459 | $13.4M | $19.1M | |
| Lease security deposit | $106.3K | $96.9K | |
| Total Liabilities | $38.8M | $38.9M | |
| Common Stock - $0.05 par value; 1,000,000,000 shares authorized, 3,067,059 shares issued and outstanding at December 31, 2025 and 2024 | $153.4K | $153.4K | |
| Additional paid-in capital | $14.1M | $13.9M | |
| Accumulated deficit | -$21.2M | -$20.2M | |
| Total Equity (Deficit) | -$6.2M | -$5.4M | -$3.0M |
| Total Liabilities and Equity (Deficit) | $32.6M | $33.4M | |
| Long term debt, net of discount, current | $6.5K | $451.9K | |
| Liabilities held for sale, net of discount | $231.2K | ||
| Debt issuance cost | $197.5K | ||
| Preferred stock, shares authorized | 10.0M shares | ||
| Common stock, par value | $0.05 | $0.05 | |
| Common stock, shares authorized | 1.0B shares | 1.0B shares | |
| Common stock, shares issued | 3.1M shares | 3.1M shares | |
| Common stock, shares outstanding | 3.1M shares | 3.1M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $1.0M | $680.3K | |
| Accounts receivable, net | $2.3M | $2.6M | |
| Other receivable | $123.1K | ||
| Prepaid expenses and other assets | $149.8K | $233.2K | |
| Assets held for sale | $4.0M | ||
| Total current assets | $7.6M | $3.5M | |
| Restricted cash | $842.1K | $711.6K | |
| Property and equipment, net | $23.1M | $28.1M | |
| Goodwill | $1.1M | $1.1M | $1.1M |
| Total Assets | $32.6M | $33.4M | |
| Accounts payable and accrued liabilities | $6.3M | $6.6M | |
| Dividends payable | $89.6K | $53.1K | |
| Current long-term debt, net of discount of $6,544 and $451,936, respectively | $10.9M | $11.5M | |
| Lines of credit | $325.2K | $799.8K | |
| Liabilities held for sale, net of discount of $231,196 | $6.1M | ||
| Other current liabilities | $725.0K | ||
| Total Current Liabilities | $25.3M | $19.6M | |
| Long-term debt, net of discount of $197,459 | $13.4M | $19.1M | |
| Lease security deposit | $106.3K | $96.9K | |
| Total Liabilities | $38.8M | $38.9M | |
| Common Stock - $0.05 par value; 1,000,000,000 shares authorized, 3,067,059 shares issued and outstanding at December 31, 2025 and 2024 | $153.4K | $153.4K | |
| Additional paid-in capital | $14.1M | $13.9M | |
| Accumulated deficit | -$21.2M | -$20.2M | |
| Total Equity (Deficit) | -$6.2M | -$5.4M | -$3.0M |
| Total Liabilities and Equity (Deficit) | $32.6M | $33.4M | |
| Long term debt, net of discount, current | $6.5K | $451.9K | |
| Liabilities held for sale, net of discount | $231.2K | ||
| Debt issuance cost | $197.5K | ||
| Preferred stock, shares authorized | 10.0M shares | ||
| Common stock, par value | $0.05 | $0.05 | |
| Common stock, shares authorized | 1.0B shares | 1.0B shares | |
| Common stock, shares issued | 3.1M shares | 3.1M shares | |
| Common stock, shares outstanding | 3.1M shares | 3.1M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$1.0M | -$2.4M |
| Depreciation | $1.5M | $1.6M |
| Amortization of deferred loan costs and debt discount | $16.7K | $103.4K |
| Provision for credit loss | $883.0K | $1.0M |
| Gain on sale of asset | -$2.1M | |
| Loss on extinguishment of debt | $253.0K | |
| Gain on debt forgiveness | -$173.5K | |
| Accounts receivable | -$543.3K | -$1.6M |
| Prepaid expenses and other assets | -$39.8K | $1.0M |
| Accounts payable and accrued liabilities | $292.9K | $528.8K |
| Other current liabilities | $725.0K | |
| Lease security deposits | $9.4K | $34.1K |
| Cash provided by (used in) operating activities | $1.9M | -$1.8M |
| Proceeds from sale of land and building | $2.5M | |
| Purchases of property and equipment | -$443.6K | -$36.1K |
| Cash (used in) provided by investing activities | -$443.6K | $2.4M |
| Proceeds on debt, non-related party | $50.0K | $371.7K |
| Payments on debt, non-related party | -$1.2M | -$2.6M |
| Proceeds from line of credit | $464.0K | $800.0K |
| Payments on line of credit | -$331.3K | -$248 |
| Payments on related party debt | -$150.0K | |
| Dividends paid on preferred stock | -$1.0K | |
| Cash used in financing activities | -$976.7K | -$1.5M |
| Net increase (decrease) in cash, cash equivalents and restricted cash | $461.7K | -$912.8K |
| Cash paid for interest | $1.7M | $1.7M |
| Dividends declared on Series D preferred stock | $37.5K | $22.5K |
| Payoff of secured fixed rate mortgage loan | $3.7M |
No quarter-by-quarter statement was filed.
What it owns
What SELECTIS HEALTH, INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $36.9M4 Dec 31, 2025 | $43.0M4 Dec 31, 2024 | −14.1% |
| Accumulated depreciation | $13.8M4 Dec 31, 2025 | $14.9M4 Dec 31, 2024 | −6.8% |
| Property and equipment, net | $23.1M4 Dec 31, 2025 | $28.1M4 Dec 31, 2024 | −18.0% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $1.0M4 Dec 31, 2025 | $680.3K4 Dec 31, 2024 | +48.7% |
Intangibles and goodwill
Properties, in its own words
As of December 31, 2025, we owned twelve (12) long-term care facilities including a campus of three buildings in Tulsa, OK. The following table provides summary information regarding these facilities at December 31, 2025:
Total Square Feet · # of Beds
The rest of Item 2
State · Properties · Operations · Leased Operations · Operating Square Feet · Leased Square Feet · Operating Beds · Leased Beds
Arkansas · 1 · - · 1 · - · 40,737 · - · 141
Georgia (1) · 4 · 4 · - · 78,197 · - · 382 · -
Ohio · 1 · - · - · 27,500 · - · 99 · -
Oklahoma · 6 · 5 · - · 162,976 · - · 412 · -
Total · 12 · 9 · 1 · 268,673 · 40,737 · 893 · 141
(1) · As a result of the sale of Goodwill Hunting LLC on June 18, 2024 the Company had no more operating leases recorded on its consolidated balance sheet.
Effective December 5, 2025, the Company executed two Purchase and Sale Agreements, and corresponding Operations Transfer Agreements, pursuant to which the Company agreed to sell to an unrelated third party, two (2) of the Company’s skilled nursing facilities in the State of Georgia: Warrenton and Sparta. If consummated, the PSA’s would result in the Company having two (2) remaining facilities in the State of Georgia. The Company closed on this transaction in January 2026.
Effective March 5, 2026, the Company executed two Purchase and Sale Agreements, and corresponding Operations Transfer Agreements, pursuant to which the Company agreed to sell to an unrelated third party, the Company’s remaining two (2) skilled nursing facilities in the State of Georgia: Abbeville and Dodge. If this transaction closes the Company would no longer own any healthcare facilities in the State of Georgia. The closing is estimated to occur on or around June 1, 2026, subject to numerous conditions, including, without limitation, satisfactory completion of due diligence and other conditions customary in transactions of this nature. There can be no assurance that this sale transaction will close.
Item 2 of the 10-K filed Apr 15, 2026.3
Leadership
Who has led SELECTIS HEALTH, INC., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
- Chief executive officerAdam Desmond Mar 12, 2026 to May 26, 202612
- Chief executive officerKrystal Diane Eckhart May 26, 2026 to now13
- Chief executive officerLance Baller Jan 7, 2016 to Oct 7, 202214
- Chief executive officerConnie B. Brogdon Jan 27, 2015 to Jan 27, 201515
- Chief executive officerChristopher F. Brogdon Feb 21, 2014 to Aug 31, 201516
- PresidentChristopher R. Barker Jan 5, 2021 to Apr 7, 202217
- PresidentZvi Michael Rhine Jan 23, 2018 to Nov 14, 201918
- PresidentLance Baller Jan 7, 2016 to Aug 14, 201714
- PresidentChristopher F. Brogdon Oct 9, 2013 to Aug 31, 201519
- PresidentClifford L. Neuman Esq. Apr 24, 2006 to Jul 3, 201320
- Chief financial officerKrystal Diane Eckhart May 26, 2026 to now13
- Chief financial officerJames W. Creamer Iii. Dec 27, 2023 to Dec 27, 202321
- Chief financial officerBrandon Thall Dec 14, 2020 to Jul 13, 202122
- Chief financial officerZvi Michael Rhine Aug 8, 2016 to Nov 14, 201923
- Chief financial officerPhilip S. Scarborough Oct 8, 2013 to Sep 24, 201524
- Chief financial officerTodd Edwin Huss Apr 24, 2006 to Mar 23, 201125
- Chief operating officerChristopher R. Barker Jan 5, 2021 to Apr 7, 202217
- Chief operating officerAndrew L. Sink Jan 7, 2016 to Jan 23, 201726
Board members and other officers (20)
- SecretaryClifford L. Neuman Esq. Jan 14, 2016 to Aug 8, 201627
- Vice President of FinanceSandra Lee Kuwica Mar 4, 2016 to Mar 4, 201628
- SecretaryJacob Taylor Dec 14, 2016 to Dec 14, 201629
- SecretaryRyan Scates Oct 7, 2013 to Jan 7, 201530
- SecretaryPete Bloomquist Sep 8, 2008 to Jul 3, 201331
- Board memberKent Jeffrey Lund Jan 15, 2026 to now32
- Board memberDavid J. Furstenberg Jul 8, 2022 to Jul 8, 202233
- Board memberChristopher R. Barker Jul 13, 2021 to Apr 7, 202234
- Board memberJohn H. Downs Jr. Jun 21, 2019 to Jun 21, 201935
- Board memberAdam Desmond Jan 31, 2017 to now36
- Board memberJoshua Mandell Oct 18, 2017 to Mar 28, 201837
- Board memberAndrew L. Sink Jan 7, 2015 to Jul 2, 201938
- Board memberZvi Michael Rhine Jul 2, 2015 to Nov 14, 201939
- Board memberLance Baller Jul 7, 2015 to now40
- Board memberLeonard Nacht Jul 3, 2013 to Jul 3, 201341
- Board memberChristopher F. Brogdon Oct 9, 2013 to Aug 31, 201519
- Board memberSteven Mark Bathgate Oct 9, 2013 to May 23, 201642
- Board memberJohn Joseph Sheehan Jr. Oct 11, 2013 to Jan 7, 201543
- Board memberPete Bloomquist Feb 17, 2006 to Jul 3, 201344
- Board memberClifford L. Neuman Esq. Apr 24, 2006 to Aug 6, 202120
Former names
Timeline
- Oct 9, 20268-K Completed an acquisition or sale; New debt or obligation; Change to shareholders' rights45
- Sep 9, 20268-K Entered a material agreement; Completed an acquisition or sale; Change to shareholders' rights46
- Jun 24, 20268-K Entered a material agreement; Regulation FD disclosure47
- May 26, 2026New chief executive Krystal Diane Eckhart becomes CEO13
- May 20, 20268-K Executive or director change48
- May 7, 20268-K Completed an acquisition or sale49
- Mar 31, 20268-K Executive or director change50
- Mar 19, 20268-K Executive or director change51
- Mar 12, 2026New chief executive Adam Desmond becomes CEO12
- Mar 9, 20268-K Entered a material agreement52
- Jan 21, 20268-K Completed an acquisition or sale53
- Jan 6, 20268-K Executive or director change54
- Dec 30, 20258-K New debt or obligation; Change to shareholders' rights55
- Dec 9, 20258-K Entered a material agreement56
- Jan 7, 2016New chief executive Lance Baller becomes CEO14
- Jan 27, 2015New chief executive Connie B. Brogdon becomes CEO15
- Feb 21, 2014New chief executive Christopher F. Brogdon becomes CEO16
Filings
123 filings to the SEC since October 2021: 6 annual reports, 15 quarterly reports, 56 major events, 11 insider forms, 35 other. The latest 20:
- Oct 9, 202615-12G EDGAR
- Oct 9, 20268-K EDGAR
- Oct 9, 2026S-8 POS EDGAR
- Sep 9, 20268-K EDGAR
- Sep 8, 2026SC TO-T/A EDGAR
- Aug 31, 2026SC TO-T/A EDGAR
- Aug 25, 2026SC TO-T/A EDGAR
- Aug 24, 202610-Q EDGAR
- Aug 18, 2026NT 10-Q EDGAR
- Aug 18, 2026SC TO-T/A EDGAR
- Aug 11, 2026SC TO-T/A EDGAR
- Aug 3, 2026SC TO-T/A EDGAR
- Jul 16, 2026SC TO-T/A EDGAR
- Jul 13, 2026SC 14D9 EDGAR
- Jul 13, 2026SC TO-T EDGAR
- Jun 24, 20268-K EDGAR
- Jun 23, 2026SC TO-C EDGAR
- May 26, 20263 EDGAR
- May 22, 202610-Q EDGAR
- May 20, 20268-K EDGAR
The 123 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
42 open-market trades by officers, directors and large owners since October 2021: 42 buys and 0 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Dec 31, 2025 | Desmond AdamCEO | Buy | 1,300 | $2.25 | $2.9K | Form 4 |
| Dec 31, 2025 | Desmond AdamCEO | Buy | 1,300 | $2.25 | $2.9K | Form 4 |
| Dec 19, 2025 | Desmond AdamCEO | Buy | 1,345 | $2.20 | $3.0K | Form 4 |
| Dec 19, 2025 | Desmond AdamCEO | Buy | 1,345 | $2.20 | $3.0K | Form 4 |
| Dec 18, 2025 | Baller LanceDirector | Buy | 6,192 | $2.20 | $13.6K | Form 4 |
| Oct 17, 2025 | Desmond AdamCEO | Buy | 2,800 | $1.75 | $4.9K | Form 4 |
| Oct 17, 2025 | Desmond AdamCEO | Buy | 2,800 | $1.75 | $4.9K | Form 4 |
| Oct 9, 2025 | Desmond AdamCEO | Buy | 240 | $1.74 | $418 | Form 4 |
| Oct 9, 2025 | Desmond AdamCEO | Buy | 240 | $1.74 | $418 | Form 4 |
| Oct 6, 2025 | Desmond AdamCEO | Buy | 700 | $2.10 | $1.5K | Form 4 |
| Oct 6, 2025 | Desmond AdamCEO | Buy | 700 | $2.10 | $1.5K | Form 4 |
| Aug 1, 2025 | Desmond AdamCEO | Buy | 619 | $2.40 | $1.5K | Form 4 |
| Aug 1, 2025 | Desmond AdamCEO | Buy | 619 | $2.40 | $1.5K | Form 4 |
| Jul 15, 2025 | Desmond AdamCEO | Buy | 161 | $2.44 | $393 | Form 4 |
| Jul 15, 2025 | Desmond AdamCEO | Buy | 161 | $2.44 | $393 | Form 4 |
| Jun 12, 2025 | Desmond AdamCEO | Buy | 360 | $1.61 | $580 | Form 4 |
| Jun 12, 2025 | Desmond AdamCEO | Buy | 360 | $1.61 | $580 | Form 4 |
| Jun 11, 2025 | Desmond AdamCEO | Buy | 570 | $1.79 | $1.0K | Form 4 |
| Jun 11, 2025 | Desmond AdamCEO | Buy | 570 | $1.79 | $1.0K | Form 4 |
| Jun 9, 2025 | Desmond AdamCEO | Buy | 730 | $1.60 | $1.2K | Form 4 |
All 42 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
SEC filer profile
How SELECTIS HEALTH, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARSELECTIS HEALTH, INC.1
- CIK0000727346
- Employer ID (EIN)87-03402063
- Filer statusNon-accelerated filer an emerging growth company; a smaller reporting company; a shell company3
- Incorporated inUtah3
- Fiscal year endsDecember 311
- Industry code (SIC)6798 Real Estate Investment Trusts1
- SEC reviewing officeOffice of Real Estate & Construction, Division of Corporation Finance1
- Business address8480 E. Orchard Road, Suite 4900, Greenwood Village, CO 801111
- Phone720-680-08081
- Shares outstanding3,067,059 as of Aug 21, 202611
- Public float$4.0M as of Jun 30, 20253
- AuditorWithumSmith+Brown, PC, New York, NY PCAOB ID 1003
- On EDGAR sinceMay 14, 19961
- Filings788 in all: 8-K (260), 4 (131), 10-Q (55), NT 10-Q (53), 10QSB (36), 8-K/A (29), NT 10-K (29), 3 (22)1
All 46 form types
10-K (19), SC 13D/A (13), UPLOAD (12), 10KSB (11), D (11), SC 13D (10), 10QSB/A (9), SC TO-T/A (9), CORRESP (7), D/A (7), SC 13G/A (6), 10KSB/A (5), 4/A (5), DEF 14A (5), 10-K/A (4), 10-K405/A (4), NT 10-Q/A (4), SC 13G (4), 10-Q/A (3), 5 (2), PRE 14A (2), REGDEX (2), SC 14D9 (2), SC TO-C (2), SC TO-T (2), 10-K405 (1), 15-12G (1), 424B3 (1), 5/A (1), DEF 14C (1), DEFR14A (1), PRE 14C (1), PRER14A (1), PRER14C (1), REGDEX/A (1), S-8 (1), S-8 POS (1), SB-2 (1)
- Latest filingsAnnual report (10-K) Apr 15, 2026
Quarterly report (10-Q) Aug 24, 2026
Proxy statement (DEF 14A) Oct 20, 2022
Latest 8-K (8-K) Oct 9, 2026
Risk factors and legal proceedings
Legal proceedings
The Company and/or its affiliated subsidiaries provide patient care at or through their facilities. As such, the Company and its affiliated subsidiaries are subject from time to time to claims of negligence resulting in injury or death to residents. The Company maintains comprehensive general liability insurance and professional liability insurance in sufficient amounts to cover most material exposure resulting from these claims. The cost of defense is generally covered by these liability policies subject to reasonable reserves and deductibles. Nevertheless the Company does have exposure to these claims which in some cases can be material. There can be no assurance that the Company’s portfolio of insurance products will be adequate to cover all potential exposure or prevent material adverse financial losses.
The following represent some of the matters pending as of the date of this Report:
Hines v. Global Abbeville LLC, d/b/a Glen Eagle, et al, Superior Court of Warren County, State of Georgia, Civil Action No.2023-CV-094
This is a personal injury lawsuit filed on September 11, 2023 against various defendants arising from injuries several months after being admitted to the Glen Eagle facility. The complaint alleges that the facility was negligent in the care administered to the plaintiff which resulted in the injuries, which the Company denies. The Company has referred the litigation to its insurance company for management and believes that its exposure in this matter is de minimus.
The opening of Item 3, Legal Proceedings.3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17SEC EDGARChristopher R. Barker, President
- 18SEC EDGARZvi Michael Rhine, President
- 19SEC EDGARChristopher F. Brogdon, President
- 20SEC EDGARClifford L. Neuman Esq., President
- 21
- 22
- 23
- 24
- 25
- 26
- 27SEC EDGARClifford L. Neuman Esq., Secretary
- 28
- 29SEC EDGARJacob Taylor, Secretary
- 30SEC EDGARRyan Scates, Secretary
- 31SEC EDGARPete Bloomquist, Secretary
- 32SEC EDGARKent Jeffrey Lund, Board member
- 33SEC EDGARDavid J. Furstenberg, Board member
- 34SEC EDGARChristopher R. Barker, Board member
- 35SEC EDGARJohn H. Downs Jr., Board member
- 36SEC EDGARAdam Desmond, Board member
- 37SEC EDGARJoshua Mandell, Board member
- 38SEC EDGARAndrew L. Sink, Board member
- 39SEC EDGARZvi Michael Rhine, Board member
- 40SEC EDGARLance Baller, Board member
- 41SEC EDGARLeonard Nacht, Board member
- 42SEC EDGARSteven Mark Bathgate, Board member
- 43
- 44SEC EDGARPete Bloomquist, Board member
- 45
- 46
- 47
- 48SEC EDGARExecutive or director change
- 49SEC EDGARCompleted an acquisition or sale
- 50SEC EDGARExecutive or director change
- 51SEC EDGARExecutive or director change
- 52SEC EDGAREntered a material agreement
- 53SEC EDGARCompleted an acquisition or sale
- 54SEC EDGARExecutive or director change
- 55
- 56SEC EDGAREntered a material agreement